PAX Labs, headquartered in United States, remains privately held in the cannabis / vaporizer hardware space. The latest valuation stands at $1.7B. No public ticker exists for the company.
1 valuation. The latest, $1.7B post-money, was set by the Equity round in Apr 2019.
PAX Labs designs and markets electronic vaporizers for dry herb and cannabis oil, with a product line that includes the PAX 3 (compatible with both extracts and plant matter), the PAX 2 flower vaporizer, and the PAX Era cannabis oil pen-and-pod system, plus a companion app for customizing each vapor session. The Juul e-cigarette was originally developed inside the company before being spun out as a separate business in 2017, when the vaporizer unit took the PAX Labs name.
Founded in San Francisco, California in 2007 by Stanford graduate students Adam Bowen and James Monsees, PAX Labs closed a $420 million equity round in April 2019 that valued the company at $1.7 billion, and it has supplied agreements with Canadian cannabis producers Aurora Cannabis, Aphria, OrganiGram Holdings, and The Supreme Cannabis Company.
Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds PAX Labs.
Often trade at a premium or discount to NAV.
Platforms match existing holders with buyers. PAX Labs availability at any moment is set by the holders.
High minimums, transfer approval, company right-of-first-refusal.
Valuations, rounds and IPO status for every company in the directory — PAX Labs included.
The last valuation is $1.7B.
Lead investors for each round are in the funding timeline.
The closest cannabis / vaporizer hardware peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. PAX Labs is a private company; its shares do not trade on a public exchange.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
